Announcements Trials
Browse Landscape

Phase

Phase 2/3 1

Status

Completed 2Terminated 1Recruiting 1

Sponsor Class

OTHER 37NIH 2OTHER_GOV 1INDUSTRY 1

Study Type

Observational 1Interventional 1

Sponsor

Conditions

Breast Neoplasms 309Neoplasms 269Prostatic Neoplasms 189Precursor Cell Lymphoblastic Leukemia-Lymphoma 186Lymphoma 184Leukemia, Lymphocytic, Chronic, B-Cell 161Melanoma 158Leukemia 154Lymphoma, Non-Hodgkin 149Leukemia, Myeloid, Acute 149Brain Neoplasms 143Carcinoma, Non-Small-Cell Lung 141Lymphoma, Large B-Cell, Diffuse 128Colonic Neoplasms 128Lymphoma, Follicular 123Burkitt Lymphoma 119Ovarian Neoplasms 117Lung Neoplasms 116Glioblastoma 116Lymphoma, Mantle-Cell 114Unspecified Adult Solid Tumor, Protocol Specific 107Rectal Neoplasms 103Sarcoma 102Multiple Myeloma 102Gliosarcoma 102Hodgkin Disease 97Carcinoma, Renal Cell 97Lymphoma, B-Cell, Marginal Zone 96Astrocytoma 95Carcinoma, Ovarian Epithelial 93

Interventions

Etanercept 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Completed × NIH × Metabolic Syndrome × Clear all
NCT00111956 2017-10-06

Effects of Tumor Necrosis Factor (TNF)-Alpha Antagonism in Patients With Metabolic Syndrome

National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)

Phase 2/3 Completed
56 enrolled

Inflammation, Metabolic Syndrome

NCT00559390 2013-04-05

PCOS

Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)

Completed
136 enrolled

Menstruation Disturbances, Polycystic Ovary Syndrome, Metabolic Syndrome

Data powered by HemOnc (CC BY 4.0) Colophon âš¡